Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Effect of pine bark extract (Pycnogenol) on symptoms of knee osteoarthritis.

Cisár P, Jány R, Waczulíková I, Sumegová K, Muchová J, Vojtassák J, Duraćková Z, Lisý M, Rohdewald P.

Phytother Res. 2008 Aug;22(8):1087-92. doi: 10.1002/ptr.2461.

PMID:
18570266
2.

Protein carbonyls as a biomarker of foetal-neonatal hypoxic stress.

Zitnanová I, Sumegová K, Simko M, Maruniaková A, Chovanová Z, Chavko M, Duracková Z.

Clin Biochem. 2007 May;40(8):567-70. Epub 2006 Nov 21.

PMID:
17321511
3.

Activity of paraoxonase 1 (PON1) and its relationship to markers of lipoprotein oxidation in healthy Slovaks.

Sumegová K, Blazícek P, Waczulíková I, Zitnanová I, Duracková Z.

Acta Biochim Pol. 2006;53(4):783-7. Epub 2006 Nov 14.

4.

Single and multiple dose pharmacokinetics of maritime pine bark extract (pycnogenol) after oral administration to healthy volunteers.

Grimm T, Skrabala R, Chovanová Z, Muchová J, Sumegová K, Liptáková A, Duracková Z, Högger P.

BMC Clin Pharmacol. 2006 Aug 3;6:4.

5.

Activity of paraoxonase 1 and lipid profile in healthy children.

Sumegová K, Nagyová Z, Waczulíková I, Zitnanová I, Duracková Z.

Physiol Res. 2007;56(3):351-7. Epub 2006 Jun 22.

6.

Inhibition of NF-kappaB activation and MMP-9 secretion by plasma of human volunteers after ingestion of maritime pine bark extract (Pycnogenol).

Grimm T, Chovanová Z, Muchová J, Sumegová K, Liptáková A, Duracková Z, Högger P.

J Inflamm (Lond). 2006 Jan 27;3:1.

7.

Inhibition of COX-1 and COX-2 activity by plasma of human volunteers after ingestion of French maritime pine bark extract (Pycnogenol).

Schäfer A, Chovanová Z, Muchová J, Sumegová K, Liptáková A, Duracková Z, Högger P.

Biomed Pharmacother. 2006 Jan;60(1):5-9. Epub 2005 Oct 26.

PMID:
16330178

Supplemental Content

Loading ...
Support Center